NCT01608815View on ClinicalTrials.gov

Study of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine in Japanese Subjects

PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

December 31, 2012

Conditions
Salmonella InfectionsTyphoid FeverBacterial Infections
Interventions
BIOLOGICAL

Typhoid Vi polysaccharide

0.5 mL, Intramuscular

Trial Locations (3)

Unknown

Nagoya

Osaka

Shinjuku

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT01608815 - Study of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine in Japanese Subjects | Biotech Hunter | Biotech Hunter